The global narcolepsy therapeutics market is expected to
reach USD 3.85 billion by 2025, according to a new report by Grand View
Research, Inc. The increasing awareness about this sleep disorder among public
and healthcare providers is a key factor contributing to the market growth.
The Narcolepsy Network has estimated that out
of every 2,000 people 1 is afflicted by this condition. Moreover, Narcolepsy UK
states that around 25% patients are identified and remaining 75% are untreated
as they remain undiagnosed or are misdiagnosed, which is alarming. Some
organizations and networks are constantly working to spread awareness about
this condition among the patients and physicians.
Browse full research report on Narcolepsy
Therapeutics Market:
https://www.grandviewresearch.com/industry-analysis/narcolepsy-therapeutics-market
Further key
findings from the report suggest:
- The narcolepsy therapeutics market is expected
to grow substantially owing to the worldwide increasing incidence of this
disorder.
- Narcolepsy with cataplexy was identified as
the largest type segment in 2016. It is expected to retain its position
throughout the forecast period owing to the rising cases of cataplexy in
patients suffering from narcolepsy.
- Narcolepsy without cataplexy is likely to
witness the fastest growth over the forecast period due to increasing
awareness about Excessive Daytime Sleepiness (EDS) through various
mediums, such as awareness campaigns
- Sodium oxybate dominated the product segment
in terms of revenue share in the year 2016, and it is also expected to be
the fastest growing segment over the forecast period. Drugs belonging to
this class have higher costs and favorable coverage policies.
- Xyrem is the only FDA-approved drug in this
category and is extensively prescribed for the treatment of cataplexy and
EDS. American Academy of Sleep Medicine (ASSM) recommends it as a standard
treatment of this disorder.
- Europe dominated the regional market in terms
of revenue share in 2016 because of increase in capital investments and
existence of established healthcare infrastructure along with a large
target population
- The H1N1 influenza postvaccination pandemic of
the year 2009 has resulted in growth of number of narcolepsy patients
- Asia Pacific is likely to exhibit fastest
growth during the forecast period due to the rising healthcare expenditure
in this region, rising awareness among people, highest prevalence in
Japan, and presence of emerging economies such as China & India
- Some of the major market players are Jazz
Pharmaceuticals PLC;Teva Pharmaceutical Industries Ltd.;Graymark
Healthcare, Inc.;Addrenex Pharmaceuticals, Inc.; and BIOPROJET.
- Mergers and acquisitions are strategic
initiatives undertaken by these market players in an attempt to remain
competitive. In addition, companies are expanding their geographical
presence to untapped markets.
Browse request sample of this report by
Grand View Research: https://www.grandviewresearch.com/industry-analysis/narcolepsy-therapeutics-market/request/rs1
Grand
View Research has segmented the global narcolepsy therapeutics market on the
basis of type, product, and region:
Narcolepsy
Therapeutics Type Outlook (Revenue, USD Million, 2014 - 2025)
- Narcolepsy with
Cataplexy
- Narcolepsy Without
Cataplexy
- Secondary Narcolepsy
Narcolepsy
Therapeutics Product Outlook (Revenue, USD Million, 2014 - 2025)
- Central Nervous
System Stimulants
- Sodium Oxybate
- Selective Serotonin
Reuptake Inhibitor
- Tricyclic
Antidepressants
- Others
Narcolepsy
Therapeutics Regional Outlook (Revenue, USD Million, 2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- Asia Pacific
- Japan
- China
- Latin America
- Brazil
- Middle East &
Africa
- South Africa
About Grand View Research
Grand View Research, Inc. is a U.S. based market
research and consulting company, registered in the State of California and
headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
No comments:
Post a Comment